Londamocitinib; JAK1-IN-7; AZD4604; Saukewa: JAC34RRR7S

Sunan Sinadari:

(2R)-N-(3-{5-fluoro-2-[2-fluoro-3-(methanesulfonyl)anilino]pyrimidin-4-yl}-1H-indol-7-yl)-3-methoxy-2- (4-methylpiperazin-1-yl) propanamide

Lambar SMILES:

O=C(NC1=CC=CC2=C1NC=C2C3=NC(NC4=CC=CC(S(=O)(C)=O)=C4F)=NC=C3F)[C@H](N5CCN(C) CC5) COC

Lambar InChi:

InChi=1S/C28H31F2N7O4S/c1-36-10-12-37(13-11-36)22(16-41-2)27(38)33-21-8-4-6-17-18(14- 31-26 (17)21)25-19 (29)15-32 -28(35-25)34-20-7-5-9-23(24(20)30)42(3,39)40/h4-9,14-15,22,31H,10-13,16H2 ,1-3H3,(H,33,38)(H,32,34,35)/t22-/m1/s1

InChi Key:

JNUZADQZHYFJGW-JOCHJYFZSA-N

Mabuɗin kalma:

2241039-81-4;CAS:2241039-81-4;CAS:2241039-81-4;Londamocitinib;JAK1-IN-7;AZD4604;AZD-4604；7S34RRR

Solubility: 

Ajiya:Dry, duhu kuma a 0 - 4 C na gajeren lokaci (kwanaki zuwa makonni) ko -20 C na dogon lokaci (watanni zuwa shekaru).

Bayani:

Londamocitinib (AZD4604) shine mai hanawa na JAK1 mai inganci.

Saukewa: JAK1